Abstract
Summary
The effects of propylthiouracil (PTU) and pharmacological doses of thyroxine (T4) on growth and prolactin (PRL)-binding activity of DMBA-induced mammary tumors were studied. The hypo- or hyperthyroidism induced by these respective treatments did not affect the growth rate of established tumors, PRL binding activity in these tumors or plasma PRL in the tumor-bearing rats. In contrast, both PTU and T4 treatments caused a large reduction of PRL binding activity in the liver.
Get full access to this article
View all access options for this article.
